Skip to main content
. 2008 May;19(3):219–226. doi: 10.1155/2008/161835

TABLE 2.

Weighted average cost per day and mean duration of initial drug therapy

CAB/FLU
Voriconazole
CAB
FLU
IV Oral IV IV Oral
Dose (mg/kg) 3–6 200–400 1 400 400
Weighted average cost per day ($) 411–709 93 71 73 22
Mean duration of initial drug therapy (days)
Completed initial therapy
 Toxicity 12.8 7.3 6.5 6.8 7.3
 No toxicity 11.3 8.5 5.3 7.4 6.7
Discontinued initial therapy
 Due to toxicity 7.4 1.2 3.2 1.4 0.8
 Due to lack of efficacy or other 11.5 4.0 4.7 5.0 3.0
Died during active treatment 8.0 0.4 4.5 4.2 0.2

The base-case analysis assumes that any unused drug remaining after administration was discarded. Because conventional amphotericin B (CAB) is indicated for several conditions other than candidemia, a sensitivity analysis was performed, in which any unused CAB remaining after administration was recycled for future use. Because the base-case analysis assumes any unused CAB remaining after administration was discarded, the choice between using a CAB dose of 0.7 mg/kg or 1.0 mg/kg is of negligible importance. Under both dosing scenarios, the weighted average number of vials required for each patient is two vials per day. FLU Fluconazole; IV Intravenous